Abnormality in hippocampal signal intensity predicts atrophy in patients with systemic lupus erythematosus. (May 2017)

• Record Type: Journal Article
• Authors: Lapa, A T; Pedro, T; Francischinelli, J; Coan, A C; Costallat, L T Lavras; Cendes, F; Appenzeller, S
• Is Part Of: Lupus. Volume 26:Number 6(2017)
• Page Start: 633
• Page End: 639
• Publication Date: 2017-05
• Subjects: Hippocampal signal abnormality -- gliosis -- cognitive impairment; Systemic lupus erythematosus -- Periodicals; 616.772005
• DOI: 10.1177/0961203316673151
• Languages: English
• ISSNs: 0961-2033

Abstract

Objectives: To quantify signal abnormalities in the hippocampus (Hsig) of patients with systemic lupus erythematosus (SLE) and to determine if Hsig predict hippocampal atrophy (HA) in SLE. Methods: We included all SLE patients and healthy age- and sex-matched individuals with two magnetic resonance imaging (MRI) scans performed with a minimum of 1 year interval. All individuals underwent a standardized neuropsychological evaluation. Individual results were converted into standard scores and compared to normative data. SLE patients were additionally assessed for disease activity (SLE Disease Activity Index (SLEDAI)), damage (Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI)), and the presence of antiphospholipid antibodies. MRI was performed on an Elscint 2 T scanner and T1 inversion recovery and T2 coronal images were used for analysis. Volumetric (HV) and signal quantification (Hsig) were determined by standardized protocols. Results: We included 54 SLE patients (48 women; mean age 32.2 ± 10.56 years). Hsig were found at study entry in 15 (45.5%) patients. Hsig in the body and tail of non-atrophic hippocampi correlated with progression of volume loss during the follow-up period ( r = 0.8, p < 0.001). The presence of Hsig in the head of atrophic hippocampi correlated with progression of HA ( r = 0.73, p = 0.005) during the same period. No correlation of Hsig and disease activity or prednisone dose was observed. Conclusion: HA is frequently observed in SLE patients and volume loss is progressive in a subgroup of patients. The evaluation of Hsig is an easy tool to determine patients that may have progressive hippocampal volume loss and should be followed more closely with MRI and cognitive evaluation.